| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Calcified versus noncalcified atherosclerosis: Implications for evaluating cardiovascular risk
|
Nasir, Khurram
|
|
2009
|
3 |
2 |
p. 150-155
|
artikel
|
| 2 |
Cardiovascular imaging for the assessment of obesity-related cardiovascular disease
|
Makaryus, Amgad N.
|
|
2009
|
3 |
2 |
p. 89-94
|
artikel
|
| 3 |
Carotid intima-media thickness and carotid plaques in cardiovascular risk assessment
|
Daneshvar, Samuel A.
|
|
2009
|
3 |
2 |
p. 121-130
|
artikel
|
| 4 |
Contemporary strategies for weight loss and cardiovascular disease risk factor modification
|
Hill, Alison M.
|
|
2009
|
3 |
2 |
p. 109-118
|
artikel
|
| 5 |
Diets and dieting: Who wins, who loses?
|
Katz, David L.
|
|
2009
|
3 |
2 |
p. 81-82
|
artikel
|
| 6 |
Effects of rimonabant on progression of atherosclerosis: Increased risks and doubtful benefits
|
Jean-Louis, Girardin
|
|
2009
|
3 |
2 |
p. 79-80
|
artikel
|
| 7 |
Is myeloperoxidase a useful marker to predict the risk of cardiovascular events?
|
Arsenault, Benoit J.
|
|
2009
|
3 |
2 |
p. 137-143
|
artikel
|
| 8 |
Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (the JUPITER trial)
|
Wong, Nathan D.
|
|
2009
|
3 |
2 |
p. 83-85
|
artikel
|
| 9 |
Multiple biomarker assessment in primary prevention of cardiovascular disease
|
Daniels, Lori B.
|
|
2009
|
3 |
2 |
p. 131-136
|
artikel
|
| 10 |
Obesity, anemia, and cardiovascular risk in patients with chronic kidney disease: Overview and pathophysiologic insights
|
Miller, Andrew C.
|
|
2009
|
3 |
2 |
p. 102-108
|
artikel
|
| 11 |
Optimal dietary intake for cardiovascular risk reduction
|
Miller, Wendy M.
|
|
2009
|
3 |
2 |
p. 95-101
|
artikel
|
| 12 |
Short-term versus lifetime risk assessment for cardiovascular disease: Pros, cons, and clinical implications
|
Wilkins, John T.
|
|
2009
|
3 |
2 |
p. 144-149
|
artikel
|
Tijdschrift beschrijving